| 000 | 01871 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518062652.0 | ||
| 264 | 0 | _c20200302 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood.2019001617 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVisco, Carlo | |
| 245 | 0 | 0 |
_aEltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study. _h[electronic resource] |
| 260 |
_bBlood _c11 2019 |
||
| 300 |
_a1708-1711 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBenzoates _xadverse effects |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazines _xadverse effects |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPurpura, Thrombocytopenic, Idiopathic _xcomplications |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 700 | 1 | _aRodeghiero, Francesco | |
| 700 | 1 | _aRomano, Alessandra | |
| 700 | 1 | _aValeri, Federica | |
| 700 | 1 | _aMerli, Michele | |
| 700 | 1 | _aQuaresimini, Giulia | |
| 700 | 1 | _aVolpetti, Stefano | |
| 700 | 1 | _aSanti, Roberto M | |
| 700 | 1 | _aCarli, Giuseppe | |
| 700 | 1 | _aLucchini, Elisa | |
| 700 | 1 | _aPassamonti, Francesco | |
| 700 | 1 | _aRambaldi, Alessandro | |
| 700 | 1 | _aMotta, Giovanna | |
| 700 | 1 | _aBorchiellini, Alessandra | |
| 700 | 1 | _ad'Amore, Emanuele S G | |
| 700 | 1 | _aRuggeri, Marco | |
| 773 | 0 |
_tBlood _gvol. 134 _gno. 20 _gp. 1708-1711 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.2019001617 _zAvailable from publisher's website |
| 999 |
_c30160504 _d30160504 |
||